SCHEMBL10130804

SCHEMBL10130804

Nc1n[nH]c2cc(O)ccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 12/20 0.61
HSP90AB1 P08238 1/20 0.61
JAK2 O60674 3/20 0.60
ESR1 P03372 1/20 0.58
KDM4E B2RXH2 1/20 0.52
CYP3A4 P08684 1/20 0.52
GAA P10253 1/20 0.52
FGFR1 P11362 2/20 0.51
FGFR2 P21802 2/20 0.51
FGFR3 P22607 1/20 0.50
AURKA O14965 3/20 0.46
TGFBR1 P36897 3/20 0.46
AURKB Q96GD4 3/20 0.46
ROCK1 Q13464 2/20 0.46
CHUK O15111 1/20 0.46
RPS6KB1 P23443 1/20 0.46
CDK2 P24941 1/20 0.46
KDR P35968 1/20 0.46
SYK P43405 1/20 0.46
JAK3 P52333 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3359710 0.85 FGFR1 (0.72) PDPK1HSP90AB1JAK2FGFR1FGFR2
SCHEMBL10130802 0.83 JAK2 (0.60) PDPK1HSP90AB1JAK2ESR1KDM4E
Tert-Butyl Formate SCHEMBL27949495 0.82 PDPK1 (0.44) PDPK1HSP90AB1JAK2ESR1KDM4E
Hydrochloric Acid SCHEMBL10369298 0.82 JAK2 (0.58) PDPK1HSP90AB1JAK2ESR1KDM4E
SCHEMBL6485141 0.81 PDPK1 (0.71) PDPK1HSP90AB1JAK2CYP3A4FGFR1
SCHEMBL6478526 0.79 GSK3B (0.58) PDPK1HSP90AB1JAK2ESR1FGFR1
SCHEMBL922069 0.78 PDPK1 (0.65) PDPK1JAK2KDM4ECYP3A4GAA
SCHEMBL176952 0.78 PDPK1 (0.59) PDPK1HSP90AB1JAK2ESR1KDM4E
SCHEMBL13184208 0.78 HSP90AB1 (0.59) PDPK1HSP90AB1JAK2ESR1KDM4E
SCHEMBL6488089 0.76 JAK2 (0.65) PDPK1JAK2FGFR1FGFR2FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1820503-B1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them PFIZER ITALIA SRL (IT) 2012-02-22 EP disclosed
EP-1432416-B1 AMINOINDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PFIZER ITALIA SRL (IT) 2011-01-19 EP disclosed
US-7511136-B2 Aminoindazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2009-03-31 US disclosed
US-7511136-B2 Aminoindazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2009-03-31 US disclosed
EP-1820503-A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them Pfizer Italia S.r.l. (IT) 2007-08-22 EP disclosed
EP-0090972-B1 INDAZOLE DERIVATIVES Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1990-05-30 EP disclosed
US-4533731-A ANTIINFLAMMATORY AGENTS ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1985-08-06 US disclosed
EP-0090972-A2 Indazole derivatives Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1983-10-12 EP disclosed